Onconetix Inc. (ONCO)
NASDAQ: ONCO
· Real-Time Price · USD
0.07
0.00 (1.01%)
At close: May 08, 2025, 3:59 PM
0.07
-0.14%
After-hours: May 08, 2025, 07:16 PM EDT
1.01% (1D)
| Bid | 0.07 |
| Market Cap | 3.13M |
| Revenue (ttm) | 1.87M |
| Net Income (ttm) | -51.6M |
| EPS (ttm) | -87.25 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.08 |
| Volume | 4,208,928 |
| Avg. Volume (20D) | 8,818,416 |
| Open | 0.08 |
| Previous Close | 0.07 |
| Day's Range | 0.07 - 0.08 |
| 52-Week Range | 0.05 - 21.40 |
| Beta | 3.49 |
About ONCO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ONCO
Website n/a
3 months ago
+34.06%
Onconetix shares are trading higher. The company a...
Unlock content with
Pro Subscription
4 months ago
-13.92%
Onconetix shares are trading lower after the company announced it received a Nasdaq notice for a late quarterly report and subsequent filing.
2 months ago · accessnewswire.com
Onco-Innovations' Inka Health Innovative AI-Driven Oncology Study Paves the Way for New ResearchVANCOUVER, BC / ACCESS Newswire / February 27, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding ...
2 months ago · accessnewswire.com
Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety ProfileVANCOUVER, BC / ACCESS Newswire / February 24, 2025 / Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding it...
